We use cookies to give you the best possible service. You can choose which cookies you would like us to set. Please note that depending on your settings, not all features of the page may be available. Further information can be found in our privacy policy.

Cookies we use

Here you can manage your cookie settings.

Necessary

black.t Analytics

Google Analytics

This is how you manage cookies

Deleting / revoking cookies
You can manage cookies under the privacy policy at any time and revoke your selection.

Administration of site-specific cookies
If you want to know which site-specific cookies have been stored, check the privacy and cookie settings of your preferred browser.

Block cookies
In most modern browsers, you can set that no cookies should be stored on your device. The downside is that you have to make manual settings every time you visit a website again. Some services and features may not work properly then (eg log in with your profile).

Accept Decline

+49 2428 8096-44

Common Technical Document

The eCTD is the electronic version of the modular Common Technical Document (CTD) system established by the International Council of Harmonisation of Technical Requirements (ICH), which is mandatory for applications for a Marketing Authorisation of medical products for human use within the European Union (EMA), and Japan (MHLW. As of 2017, FDA only accepts New Drug Applications (NDAs), Abbreviated NDAs (ANDAs), and Biologics License Applications (BLAs) using eCTD format. Commercial Investigational New Drug Applications (INDs) and Master Files are also now required to use eCTD format (2018).

Advantages of eCTDs

A vital resource intensive part of the introduction of medicinal products to either your national or the international market is following and fulfilling respective standards and guidelines for the submission of applications, amendments, supplements, and reports. By implementing the eCTD, the ICH sought to reduce unnecessary stumbling blocks.

Avoid Duplicative Testing

Duplicative animal and human testing are time- and cost-intensive. Centralised standards on testing procedures and study evaluation will save you precious time and money when wanting to expand your market.

Simultaneous Submission

eCTD submission enables you to file for approval of your medicinal product in three different regions at the same time - Europe, Japan, USA - without having to adjust all of your documents according to the specific regional regulatories.

Reviewer Efficiency

Due to the implementation of the eCTD standards, reviewers were able to develop respective review standards, saving valuable time in introducing products to the market.

Faster Market Access

Overall, the avoidance of duplicate testing, the possibility of simultaneous submission, and the boost in reviewer efficiency lead to a faster product availability within the health science industry, thus leading to an increased chance of your product`s success.

IASON consulting and eCTDs

Throughout the past several years, IASON consulting has witnessed a lot of changes within the health science industry, including the implementation and enforcement of standardised documentation and application. Our consultants are specialised in supporting and guiding our clients through this jungle of complex medicinal product approval, and finding and following the right path to make the project a success.

Contact

Should you require our assistance in producing eCTDs, please do not hesitate to contact us.

Contact

Cookies we use

Necessary

black.t Analytics

Google Analytics

This is how you manage cookies

Consulting

Scientific Documents

Management

Professional Services

Contact

Common Technical Document

Advantages of eCTDs

IASON consulting and eCTDs

Contact